Titre : Vie privée

Vie privée : Questions médicales fréquentes

Termes MeSH sélectionnés :

Cognitive Dysfunction
{ "@context": "https://schema.org", "@graph": [ { "@type": "MedicalWebPage", "name": "Vie privée : Questions médicales les plus fréquentes", "headline": "Vie privée : Comprendre les symptômes, diagnostics et traitements", "description": "Guide complet et accessible sur les Vie privée : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.", "datePublished": "2024-06-09", "dateModified": "2025-03-06", "inLanguage": "fr", "medicalAudience": [ { "@type": "MedicalAudience", "name": "Grand public", "audienceType": "Patient", "healthCondition": { "@type": "MedicalCondition", "name": "Vie privée" }, "suggestedMinAge": 18, "suggestedGender": "unisex" }, { "@type": "MedicalAudience", "name": "Médecins", "audienceType": "Physician", "geographicArea": { "@type": "AdministrativeArea", "name": "France" } }, { "@type": "MedicalAudience", "name": "Chercheurs", "audienceType": "Researcher", "geographicArea": { "@type": "AdministrativeArea", "name": "International" } } ], "reviewedBy": { "@type": "Person", "name": "Dr Olivier Menir", "jobTitle": "Expert en Médecine", "description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale", "url": "/static/pages/docteur-olivier-menir.html", "alumniOf": { "@type": "EducationalOrganization", "name": "Université Paris Descartes" } }, "isPartOf": { "@type": "MedicalWebPage", "name": "Législation comme sujet", "url": "https://questionsmedicales.fr/mesh/D007878", "about": { "@type": "MedicalCondition", "name": "Législation comme sujet", "code": { "@type": "MedicalCode", "code": "D007878", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "N03.706.615" } } }, "about": { "@type": "MedicalCondition", "name": "Vie privée", "alternateName": "Privacy", "code": { "@type": "MedicalCode", "code": "D018907", "codingSystem": "MeSH" } }, "author": [ { "@type": "Person", "name": "Erman Ayday", "url": "https://questionsmedicales.fr/author/Erman%20Ayday", "affiliation": { "@type": "Organization", "name": "Computer Engineering Department, Bilkent University, 06800 Ankara, Turkey." } }, { "@type": "Person", "name": "Kai-Chih Chang", "url": "https://questionsmedicales.fr/author/Kai-Chih%20Chang", "affiliation": { "@type": "Organization", "name": "Department of Electrical and Computer Engineering, The University of Texas at Austin, Austin, TX 78712, USA." } }, { "@type": "Person", "name": "Suzanne Barber", "url": "https://questionsmedicales.fr/author/Suzanne%20Barber", "affiliation": { "@type": "Organization", "name": "Department of Electrical and Computer Engineering, The University of Texas at Austin, Austin, TX 78712, USA." } }, { "@type": "Person", "name": "Yahan Yang", "url": "https://questionsmedicales.fr/author/Yahan%20Yang", "affiliation": { "@type": "Organization", "name": "State Key Laboratory of Ophthalmology, Zhongshan Ophthalmic Centre, Sun Yat-sen University, Guangdong Provincial Key Laboratory of Ophthalmology and Vision Science, Guangdong Provincial Clinical Research Center for Ocular Diseases, Guangzhou, Guangdong." } }, { "@type": "Person", "name": "Haotian Lin", "url": "https://questionsmedicales.fr/author/Haotian%20Lin", "affiliation": { "@type": "Organization", "name": "State Key Laboratory of Ophthalmology, Zhongshan Ophthalmic Centre, Sun Yat-sen University, Guangdong Provincial Key Laboratory of Ophthalmology and Vision Science, Guangdong Provincial Clinical Research Center for Ocular Diseases, Guangzhou, Guangdong." } } ], "citation": [ { "@type": "ScholarlyArticle", "name": "Influence of dexmedetomidine on postoperative cognitive dysfunction in the elderly: A meta-analysis of randomized controlled trials.", "datePublished": "2022-07-10", "url": "https://questionsmedicales.fr/article/35810480", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1002/brb3.2665" } }, { "@type": "ScholarlyArticle", "name": "Pro-inflammatory cytokines and cognitive dysfunction among patients with bipolar disorder and major depression.", "datePublished": "2022-06-29", "url": "https://questionsmedicales.fr/article/35674415", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1111/pcn.13433" } }, { "@type": "ScholarlyArticle", "name": "Meta-Analysis of the Correlation between Postoperative Cognitive Dysfunction and Intraoperative Cerebral Oxygen Saturation.", "datePublished": "2022-06-01", "url": "https://questionsmedicales.fr/article/35693261", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1155/2022/3731959" } }, { "@type": "ScholarlyArticle", "name": "Relationship between postoperative biomarkers of neuronal injury and postoperative cognitive dysfunction: A meta-analysis.", "datePublished": "2023-04-25", "url": "https://questionsmedicales.fr/article/37098084", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1371/journal.pone.0284728" } }, { "@type": "ScholarlyArticle", "name": "Presynaptic membrane protein dysfunction occurs prior to neurodegeneration and predicts faster cognitive decline.", "datePublished": "2022-12-08", "url": "https://questionsmedicales.fr/article/36478661", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1002/alz.12890" } } ], "breadcrumb": { "@type": "BreadcrumbList", "itemListElement": [ { "@type": "ListItem", "position": 1, "name": "questionsmedicales.fr", "item": "https://questionsmedicales.fr" }, { "@type": "ListItem", "position": 2, "name": "Organisations et économie des soins de santé", "item": "https://questionsmedicales.fr/mesh/D004472" }, { "@type": "ListItem", "position": 3, "name": "Contrôle social formel", "item": "https://questionsmedicales.fr/mesh/D012926" }, { "@type": "ListItem", "position": 4, "name": "Législation comme sujet", "item": "https://questionsmedicales.fr/mesh/D007878" }, { "@type": "ListItem", "position": 5, "name": "Vie privée", "item": "https://questionsmedicales.fr/mesh/D018907" } ] } }, { "@type": "MedicalWebPage", "name": "Article complet : Vie privée - Questions et réponses", "headline": "Questions et réponses médicales fréquentes sur Vie privée", "description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.", "datePublished": "2025-05-09", "inLanguage": "fr", "hasPart": [ { "@type": "MedicalWebPage", "name": "Diagnostic", "headline": "Diagnostic sur Vie privée", "description": "Comment évaluer la vie privée d'un patient ?\nQuels outils aident à protéger la vie privée ?\nQu'est-ce qu'une violation de la vie privée ?\nComment identifier un risque pour la vie privée ?\nQuels sont les indicateurs d'une bonne protection de la vie privée ?", "url": "https://questionsmedicales.fr/mesh/D018907?mesh_terms=Cognitive+Dysfunction&page=8#section-diagnostic" }, { "@type": "MedicalWebPage", "name": "Symptômes", "headline": "Symptômes sur Vie privée", "description": "Quels signes indiquent une atteinte à la vie privée ?\nComment les patients réagissent-ils aux violations ?\nQuels impacts psychologiques d'une violation ?\nLes patients signalent-ils souvent des violations ?\nQuels symptômes de méfiance chez les patients ?", "url": "https://questionsmedicales.fr/mesh/D018907?mesh_terms=Cognitive+Dysfunction&page=8#section-symptômes" }, { "@type": "MedicalWebPage", "name": "Prévention", "headline": "Prévention sur Vie privée", "description": "Comment prévenir les violations de la vie privée ?\nQuelles pratiques de confidentialité sont recommandées ?\nComment sensibiliser les patients à leur vie privée ?\nQuels outils technologiques aident à la prévention ?\nComment impliquer les patients dans la protection de leur vie privée ?", "url": "https://questionsmedicales.fr/mesh/D018907?mesh_terms=Cognitive+Dysfunction&page=8#section-prévention" }, { "@type": "MedicalWebPage", "name": "Traitements", "headline": "Traitements sur Vie privée", "description": "Comment traiter une violation de la vie privée ?\nQuelles lois protègent la vie privée des patients ?\nComment former le personnel à la vie privée ?\nQuels protocoles pour protéger la vie privée ?\nComment évaluer l'efficacité des mesures de protection ?", "url": "https://questionsmedicales.fr/mesh/D018907?mesh_terms=Cognitive+Dysfunction&page=8#section-traitements" }, { "@type": "MedicalWebPage", "name": "Complications", "headline": "Complications sur Vie privée", "description": "Quelles conséquences d'une violation de la vie privée ?\nComment une violation affecte-t-elle la réputation d'un établissement ?\nQuels impacts sur la relation patient-médecin ?\nQuelles sanctions pour les violations de la vie privée ?\nComment gérer les conséquences psychologiques d'une violation ?", "url": "https://questionsmedicales.fr/mesh/D018907?mesh_terms=Cognitive+Dysfunction&page=8#section-complications" }, { "@type": "MedicalWebPage", "name": "Facteurs de risque", "headline": "Facteurs de risque sur Vie privée", "description": "Quels facteurs augmentent le risque de violation ?\nComment la technologie influence-t-elle la vie privée ?\nQuels comportements des employés sont risqués ?\nComment les politiques de l'établissement influencent-elles la vie privée ?\nQuel rôle joue la sensibilisation à la sécurité ?", "url": "https://questionsmedicales.fr/mesh/D018907?mesh_terms=Cognitive+Dysfunction&page=8#section-facteurs de risque" } ] }, { "@type": "FAQPage", "mainEntity": [ { "@type": "Question", "name": "Comment évaluer la vie privée d'un patient ?", "position": 1, "acceptedAnswer": { "@type": "Answer", "text": "Évaluer la vie privée implique d'examiner les pratiques de collecte et de stockage des données." } }, { "@type": "Question", "name": "Quels outils aident à protéger la vie privée ?", "position": 2, "acceptedAnswer": { "@type": "Answer", "text": "Des outils comme les logiciels de cryptage et les systèmes de gestion des accès sont essentiels." } }, { "@type": "Question", "name": "Qu'est-ce qu'une violation de la vie privée ?", "position": 3, "acceptedAnswer": { "@type": "Answer", "text": "Une violation se produit lorsque des informations personnelles sont divulguées sans consentement." } }, { "@type": "Question", "name": "Comment identifier un risque pour la vie privée ?", "position": 4, "acceptedAnswer": { "@type": "Answer", "text": "Identifier les risques nécessite une analyse des processus de gestion des données personnelles." } }, { "@type": "Question", "name": "Quels sont les indicateurs d'une bonne protection de la vie privée ?", "position": 5, "acceptedAnswer": { "@type": "Answer", "text": "Des politiques claires, des formations régulières et des audits fréquents sont des indicateurs clés." } }, { "@type": "Question", "name": "Quels signes indiquent une atteinte à la vie privée ?", "position": 6, "acceptedAnswer": { "@type": "Answer", "text": "Des signes incluent des fuites d'informations, des plaintes de patients ou des audits échoués." } }, { "@type": "Question", "name": "Comment les patients réagissent-ils aux violations ?", "position": 7, "acceptedAnswer": { "@type": "Answer", "text": "Les patients peuvent ressentir de l'anxiété, de la méfiance ou même changer de praticien." } }, { "@type": "Question", "name": "Quels impacts psychologiques d'une violation ?", "position": 8, "acceptedAnswer": { "@type": "Answer", "text": "Les violations peuvent entraîner stress, dépression et sentiment d'insécurité chez les patients." } }, { "@type": "Question", "name": "Les patients signalent-ils souvent des violations ?", "position": 9, "acceptedAnswer": { "@type": "Answer", "text": "Non, beaucoup de violations ne sont pas signalées par crainte de représailles ou de stigmatisation." } }, { "@type": "Question", "name": "Quels symptômes de méfiance chez les patients ?", "position": 10, "acceptedAnswer": { "@type": "Answer", "text": "Les patients peuvent poser plus de questions ou hésiter à partager des informations sensibles." } }, { "@type": "Question", "name": "Comment prévenir les violations de la vie privée ?", "position": 11, "acceptedAnswer": { "@type": "Answer", "text": "Utiliser des technologies de sécurité, former le personnel et établir des politiques claires." } }, { "@type": "Question", "name": "Quelles pratiques de confidentialité sont recommandées ?", "position": 12, "acceptedAnswer": { "@type": "Answer", "text": "Limiter l'accès aux données, anonymiser les informations et obtenir le consentement éclairé." } }, { "@type": "Question", "name": "Comment sensibiliser les patients à leur vie privée ?", "position": 13, "acceptedAnswer": { "@type": "Answer", "text": "Informer les patients sur leurs droits et les pratiques de protection des données est essentiel." } }, { "@type": "Question", "name": "Quels outils technologiques aident à la prévention ?", "position": 14, "acceptedAnswer": { "@type": "Answer", "text": "Des outils comme les VPN, le chiffrement et les systèmes de gestion des accès sont utiles." } }, { "@type": "Question", "name": "Comment impliquer les patients dans la protection de leur vie privée ?", "position": 15, "acceptedAnswer": { "@type": "Answer", "text": "Encourager les patients à poser des questions et à exprimer leurs préoccupations est crucial." } }, { "@type": "Question", "name": "Comment traiter une violation de la vie privée ?", "position": 16, "acceptedAnswer": { "@type": "Answer", "text": "Il faut informer les patients, évaluer les dommages et renforcer les mesures de sécurité." } }, { "@type": "Question", "name": "Quelles lois protègent la vie privée des patients ?", "position": 17, "acceptedAnswer": { "@type": "Answer", "text": "Des lois comme le RGPD en Europe et HIPAA aux États-Unis protègent les données personnelles." } }, { "@type": "Question", "name": "Comment former le personnel à la vie privée ?", "position": 18, "acceptedAnswer": { "@type": "Answer", "text": "Des formations régulières sur la confidentialité et la sécurité des données sont essentielles." } }, { "@type": "Question", "name": "Quels protocoles pour protéger la vie privée ?", "position": 19, "acceptedAnswer": { "@type": "Answer", "text": "Mettre en place des protocoles de consentement, de stockage et de partage des données est crucial." } }, { "@type": "Question", "name": "Comment évaluer l'efficacité des mesures de protection ?", "position": 20, "acceptedAnswer": { "@type": "Answer", "text": "Des audits réguliers et des évaluations de conformité aident à mesurer l'efficacité des mesures." } }, { "@type": "Question", "name": "Quelles conséquences d'une violation de la vie privée ?", "position": 21, "acceptedAnswer": { "@type": "Answer", "text": "Les conséquences incluent des poursuites judiciaires, des amendes et une perte de confiance." } }, { "@type": "Question", "name": "Comment une violation affecte-t-elle la réputation d'un établissement ?", "position": 22, "acceptedAnswer": { "@type": "Answer", "text": "Une violation peut gravement nuire à la réputation, entraînant une perte de patients et de revenus." } }, { "@type": "Question", "name": "Quels impacts sur la relation patient-médecin ?", "position": 23, "acceptedAnswer": { "@type": "Answer", "text": "Les violations peuvent créer de la méfiance, rendant la communication et le traitement plus difficiles." } }, { "@type": "Question", "name": "Quelles sanctions pour les violations de la vie privée ?", "position": 24, "acceptedAnswer": { "@type": "Answer", "text": "Les sanctions peuvent inclure des amendes, des poursuites et des mesures disciplinaires internes." } }, { "@type": "Question", "name": "Comment gérer les conséquences psychologiques d'une violation ?", "position": 25, "acceptedAnswer": { "@type": "Answer", "text": "Offrir un soutien psychologique et des ressources d'accompagnement est essentiel pour les patients." } }, { "@type": "Question", "name": "Quels facteurs augmentent le risque de violation ?", "position": 26, "acceptedAnswer": { "@type": "Answer", "text": "Des facteurs comme le manque de formation, des systèmes obsolètes et des politiques floues augmentent le risque." } }, { "@type": "Question", "name": "Comment la technologie influence-t-elle la vie privée ?", "position": 27, "acceptedAnswer": { "@type": "Answer", "text": "L'utilisation accrue des technologies numériques peut accroître les risques de violations de données." } }, { "@type": "Question", "name": "Quels comportements des employés sont risqués ?", "position": 28, "acceptedAnswer": { "@type": "Answer", "text": "Des comportements comme le partage d'identifiants ou l'accès non autorisé aux données sont risqués." } }, { "@type": "Question", "name": "Comment les politiques de l'établissement influencent-elles la vie privée ?", "position": 29, "acceptedAnswer": { "@type": "Answer", "text": "Des politiques claires et strictes aident à protéger la vie privée, tandis que des politiques laxistes l'exposent." } }, { "@type": "Question", "name": "Quel rôle joue la sensibilisation à la sécurité ?", "position": 30, "acceptedAnswer": { "@type": "Answer", "text": "La sensibilisation à la sécurité aide à réduire les comportements à risque et à protéger les données." } } ] } ] }

Sources (10000 au total)

Influence of dexmedetomidine on postoperative cognitive dysfunction in the elderly: A meta-analysis of randomized controlled trials.

Dexmedetomidine (Dex) is suggested to be neuroprotective. However, influence of Dex on postoperative cognitive dysfunction (POCD) in the elderly remains unknown.... We performed a meta-analysis of randomized controlled trials (RCTs) to evaluate the effect of Dex on POCD. Relevant studies were obtained by search of PubMed, Embase, and Cochrane's Library databases.... Fourteen RCTs including 1626 adults of 60 years or older who received surgery with general anesthesia were included. Because methodologically diverse scales were used for POCD, eight RCTs with POCD di... Dex is associated with a reduced risk of POCD in elderly patients receiving surgeries with general anesthesia, and the results were mainly obtained in studies with POCD diagnosed with MMSE. Based on t...

Pro-inflammatory cytokines and cognitive dysfunction among patients with bipolar disorder and major depression.

Bipolar disorder and major depressive disorder (MDD) have been demonstrated to be associated with proinflammatory states and cognitive function deficits. We aimed to investigate the differences of cog... Thirty-seven patients with BDI, 33 with BDII, 25 with MDD, and 54 age-, sex-matched controls were enrolled. All patients had a clinical global impression-severity scale ≤2. Serum levels of proinflamma... Patients with BDI had higher levels of sTNF-αR1 than patients with MDD and controls (P < 0.001). Patients with BDI performed worse on WLMT, WCST, 2-back task, divided attention_visual and divided atte... Patients with BDI had higher levels of sTNF-αR1 and cognitive function impairments than the remaining groups. Future studies are needed to explore the pathophysiology of sTNF-αR1 in the contribution o...

Meta-Analysis of the Correlation between Postoperative Cognitive Dysfunction and Intraoperative Cerebral Oxygen Saturation.

This study is aimed at performing a meta-analysis for discussing the association between postoperative cognitive dysfunction (POCD) and cerebral cortical oxygen saturation after surgery (rSO2).... Search common English databases such as Cochrane Library, PubMed, and Embase databases to evaluate the quality of all references. According to the normalized mean difference (SMD) and 95% confidence i... A total of 7 randomized controlled trials and 564 POCD patients were included in the study, with follow-up duration of 1-12 months. All patients were divided into control and operation subgroups. In t... Lower intraoperativersO2 was associated with reduced incidence of neurological complications and renal alure as well as the length of stay in the intensive care unit and the total hospital stay....

Relationship between postoperative biomarkers of neuronal injury and postoperative cognitive dysfunction: A meta-analysis.

Early biomarkers are needed to identify patients at risk of developing postoperative cognitive dysfunction (POCD). Our objective was to determine neuronal injury-related biomarkers with predictive val...

Presynaptic membrane protein dysfunction occurs prior to neurodegeneration and predicts faster cognitive decline.

Although presynaptic loss measured by cerebrospinal fluid (CSF) growth-associated protein-43 (GAP-43) is significantly involved in Alzheimer's disease (AD), the sequential association between CSF GAP-... We compared baseline CSF GAP-43 levels (n = 730) and longitudinal CSF GAP-43 changes (n = 327) in various biological stages of AD, and investigated their relationships with cross-sectional and longitu... Elevated CSF GAP43 levels were significantly associated with faster rates of hippocampal atrophy, AD-signature hypometabolism and cortical thinning, and middle temporal gray matter atrophy-related and... These findings suggest that presynaptic loss may occur prior to neurodegeneration, highlighting the importance of lowing tau aggregation and tau-related synaptic dysfunction in elderly adults and AD p...

Remote assessment of cognitive dysfunction in hematologic malignancies using web-based neuropsychological testing.

Cognitive impairment is a frequent adverse effect of cancer and its therapies. As neuropsychological assessment is not often standard of care for patients with non-CNS disease, efficient, practical as... We enrolled 22 patients with multiple myeloma (MM) or non-Hodgkin lymphoma (NHL) and 40 healthy controls (mean age = 56 ± 11 years, 52% male). Participants completed the BrainCheck cognitive testing b... All participants except for one control completed the online assessment measures without difficulty. Compared to controls, the cancer group demonstrated significantly lower scores in objective and sub... Remote assessment of cognitive and psychosocial functioning is feasible with patients with cancer following treatments. The BrainCheck cognitive testing battery has the potential to detect differences...